Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer.
JAMA Dermatol. 2018 Jun 1;154(6):670-675. doi: 10.1001/jamadermatol.2018.0454.
JAMA Dermatol. 2018.
PMID: 29641806
Free PMC article.
IMPORTANCE: Endocrine therapy-induced alopecia (EIA) has been anecdotally reported but not systematically described. ...
IMPORTANCE: Endocrine therapy-induced alopecia (EIA) has been anecdotally reported but not systematically descri …
Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia.
Freites-Martinez A, Chan D, Sibaud V, Shapiro J, Fabbrocini G, Tosti A, Cho J, Goldfarb S, Modi S, Gajria D, Norton L, Paus R, Cigler T, Lacouture ME.
Freites-Martinez A, et al.
JAMA Dermatol. 2019 Jun 1;155(6):724-728. doi: 10.1001/jamadermatol.2018.5071.
JAMA Dermatol. 2019.
PMID: 30840033
Free PMC article.
OBJECTIVE: To characterize the clinical presentation of patients with persistent chemotherapy-induced alopecia (pCIA) or endocrine therapy-induced alopecia after chemotherapy (EIAC) and their QOL and treatment outcomes. ...
OBJECTIVE: To characterize the clinical presentation of patients with persistent chemotherapy-induced alopecia (pCIA) or endocrine …
Item in Clipboard
Cite
Cite